Funded for HALEU growth, commercial scale expansion de-risked
- The core business sells LEU, which is the fuel used by today's nuclear power plants.
- The long-term growth driver is HALEU, a richer fuel required by many advanced reactor designs.
- A $900 million DOE task order and $560 million investment at Oak Ridge shift the story from policy risk to execution risk.
- Centrus removed all financial contingencies on its contingent LEU enrichment backlog, clearing a path for commercial expansion.
- The legacy business faces timing risk as Russia now requires export licenses for each shipment to Centrus.
A funded shot at U.S. enrichment
Centrus is one of the clearest public bets on the United States rebuilding its own uranium enrichment supply chain. The big catalyst is a secured $900 million Department of Energy task order for commercial-scale HALEU production. HALEU is a specialized nuclear fuel that many advanced reactors and hyperscaler energy projects need.
That moves the bull case into a new phase. The question is no longer whether the government will fund domestic capacity. The question is whether Centrus can build the plant and control costs. A $560 million investment launch at the Oak Ridge manufacturing facility and a new partnership with Palantir are early steps. Financial contingencies for the multi-billion dollar LEU enrichment backlog have been completely removed.
The legacy LEU business provides a cash flow bridge while the new capacity gets built. Centrus sells enrichment services and uranium products to utilities under medium- and long-term contracts. Waivers allow the company to import Russian LEU for committed deliveries through 2027, which keeps the bridge standing.
The bear case is that the bridge remains narrow and fragile. Russia requires TENEX to get a specific export license for every single shipment to Centrus. After 2027, U.S. import limits become much stricter. Centrus needs new domestic capacity or fresh supply deals to protect its long-term order book, and large-scale manufacturing expansion carries high execution risk.
Fuel sales today, factory build-out tomorrow
Centrus operates two main businesses. The LEU segment sells the enrichment component of nuclear fuel, called SWU, along with uranium products like natural uranium hexafluoride. Customers are mostly electric utilities that run existing nuclear plants.
This segment can be profitable, but revenue timing is lumpy. A few large utility orders dictate a quarter. In Q1 2026, individual SWU customer orders averaged about $13.7 million. A single delayed delivery can change reported revenue significantly.
Technical Solutions is the growth arm. It handles engineering, manufacturing, and enrichment work for the U.S. government and private clients. The primary focus is HALEU production for the DOE at Piketon, Ohio, backed by a massive $900 million task order and new execution partnerships. Definitive agreements with private customers like X-energy provide prepayments, adding non-dilutive capital for expansion.
The model breaks if the supply chain fails. Centrus relies heavily on Russian LEU from TENEX through 2027. It also needs the DOE, private capital, or customer offtake agreements to fund its Ohio and Tennessee expansion plans into real, scalable production. The company is actively exploring a joint venture with Oklo for deconversion services to capture more of the fuel cycle.
What Centrus sells
Separative Work Units
SWU is the enrichment work inside LEU. This is the main product sold to nuclear utilities in the legacy segment.
Natural uranium hexafluoride
This is uranium feed material used in the enrichment process. Centrus sells it directly or bundles it in fuel packages.
Enriched uranium product
EUP bundles uranium feed and enrichment into one sale. It lets customers buy a more complete fuel component.
HALEU
HALEU is high-assay, low-enriched uranium. It is critical for many advanced reactor designs and drives the company's growth plan.
Engineering and manufacturing services
Centrus applies its centrifuge expertise to government and private projects. This supports the goal of rebuilding domestic enrichment.
HALEU deconversion services
Centrus is exploring a commercial deconversion joint venture with Oklo. This would turn enriched material into usable fuel forms.
Two segments, different jobs
Mix is based on Q1 2026 revenue. LEU generated $44.6 million and Technical Solutions generated $32.1 million. Technical Solutions is growing rapidly while the legacy LEU segment sees lower volumes.
What could break the thesis
Russian export licenses slow or stop
High impact · Medium oddsU.S. waivers allow certain Russian LEU imports, but Russia now requires TENEX to secure a license for each export shipment to Centrus. This added bureaucracy creates timing uncertainty. There is no guarantee that future licenses will arrive on schedule.
Execution risk on massive scale-up
High impact · Medium oddsThe $900 million HALEU task order and the $560 million Oak Ridge manufacturing expansion bring heavy construction, supply chain, and operating risks. Building highly complex centrifuges at a commercial scale has steep hurdles.
Post-2027 LEU supply cliff
High impact · Medium oddsThe U.S. ban on Russian LEU imports becomes a much larger issue after 2027. Centrus has alternative sources, but they are not enough to replace TENEX supply entirely. The company must build new domestic LEU capacity or sign other supply deals to protect its long-term order book.
Government funding shifts
Medium impact · Medium oddsTechnical Solutions depends heavily on DOE contracts and appropriations. Centrus previously disclosed uncertainty tied to federal funding reviews. Even awarded contracts rely on specific task orders, options, and funded scope to generate revenue.
Customer and quarter lumpiness
Medium impact · High oddsThe legacy LEU business swings from quarter to quarter because customer deliveries are large and uneven. A small timing change can make revenue or profit look artificially better or worse than the underlying long-term trend.
In one breath
What does Centrus Energy do?
Centrus supplies nuclear fuel components to utilities and provides technical services to the U.S. government. Its main products are LEU for current reactors and HALEU for advanced reactor designs.
Why is the DOE contract important for LEU stock?
The $900 million DOE HALEU task order gives Centrus a funded path toward commercial-scale production. It confirms the strategic national security role of the company and transitions the business from demonstration to execution.
Why does Russian supply matter so much?
Centrus has relied on TENEX for a large portion of its LEU supply. While U.S. waivers help through 2027, Russia must approve exports shipment by shipment. This can delay or disrupt the legacy business.
Is Centrus already producing HALEU?
Yes. Centrus completed its Phase 2 target by delivering 900 kilograms of HALEU to the DOE in June 2025. The company is now working to transition its 16-centrifuge demonstration cascade to commercial operation.
